1-10 of 10
David L. Porter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Nausheen Ahmed, William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanova, Loretta J. Nastoupil, Miguel-Angel Perales, Richard T. Maziarz, Jamie Brower, Gunjan L. Shah, Andy I. Chen, Olalekan O. Oluwole, Stephen J. Schuster, Michael R. Bishop, Joseph P. McGuirk, Peter A. Riedell
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5346–5354.
https://doi.org/10.1182/bloodadvances.2023012549
Published: 2024
Includes: Supplemental data
Journal Articles

Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines

Clinical Trials & Observations
Guido Ghilardi, Luca Paruzzo, Jakub Svoboda, Elise A. Chong, Alexander A. Shestov, Linhui Chen, Ivan J. Cohen, Giulia Gabrielli, Sunita D. Nasta, Patrizia Porazzi, Daniel J. Landsburg, James N. Gerson, Jordan Carter, Stefan K. Barta, Rebecca Yelton, Raymone Pajarillo, Vrutti Patel, Griffin White, Hatcher J. Ballard, Elizabeth Weber, Ellen Napier, Emeline R. Chong, Joseph A. Fraietta, Alfred L. Garfall, David L. Porter, Michael C. Milone, Roderick O’Connor, Stephen J. Schuster, Marco Ruella
Journal: Blood Advances
Blood Adv (2024) 8 (3): 653–666.
https://doi.org/10.1182/bloodadvances.2023011492
Published: 2024
Includes: Supplemental data
Journal Articles

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Michael Scordo, Jessica R. Flynn, Mithat Gonen, Sean M. Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L. Porter, Stephen J. Schuster, Veronika Bachanova, Joseph Maakaron, Richard T. Maziarz, Andy I. Chen, Loretta J. Nastoupil, Joseph P. McGuirk, Olalekan O. Oluwole, Andrew Ip, Lori A. Leslie, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5579–5585.
https://doi.org/10.1182/bloodadvances.2023010302
Published: 2023
Includes: Supplemental data
Journal Articles

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

Shakthi T. Bhaskar, Vivek G. Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel-Angel Perales, Ana Alarcon Tomas, Michael R. Bishop, Joseph P. McGuirk, Richard T. Maziarz, Andy I. Chen, Veronika Bachanova, Joseph E. Maakaron, Peter A. Riedell, Olalekan O. Oluwole
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4765–4772.
https://doi.org/10.1182/bloodadvances.2022008937
Published: 2023
Journal Articles

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Clinical Trials & Observations
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R. Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanova, Loretta J. Nastoupil, Joseph P. McGuirk, Richard T. Maziarz, Olalekan O. Oluwole, Stephen J. Schuster, David L. Porter, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3192–3198.
https://doi.org/10.1182/bloodadvances.2022008294
Published: 2023
Includes: Supplemental data
Journal Articles

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

Clinical Trials & Observations
Saar Gill, Vanessa Vides, Noelle V. Frey, Elizabeth O. Hexner, Susan Metzger, Megan O'Brien, Wei-Ting Hwang, Jennifer L. Brogdon, Megan M. Davis, Joseph A. Fraietta, Avery L. Gaymon, Whitney L. Gladney, Simon F. Lacey, Anne Lamontagne, Anthony R. Mato, Marcela V. Maus, J. Joseph Melenhorst, Edward Pequignot, Marco Ruella, Maksim Shestov, John C. Byrd, Stephen J. Schuster, Donald L. Siegel, Bruce L. Levine, Carl H. June, David L. Porter
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5774–5785.
https://doi.org/10.1182/bloodadvances.2022007317
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

Andrew H. Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar I. Gill, David L. Porter, Daria V. Babushok, Ivan P. Maillard, Martin P. Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, Ximena Jordan Bruno, Wei-Ting Hwang, David Margolis, Keith W. Pratz
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3997–4005.
https://doi.org/10.1182/bloodadvances.2022007265
Published: 2022
Includes: Supplemental data
Journal Articles

Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children

Clinical Trials & Observations
Caroline Diorio, Pamela A. Shaw, Edward Pequignot, Alena Orlenko, Fang Chen, Richard Aplenc, David M. Barrett, Hamid Bassiri, Edward Behrens, Amanda M. DiNofia, Vanessa Gonzalez, Natalka Koterba, Bruce L. Levine, Shannon L. Maude, Nuala J. Meyer, Jason H. Moore, Michele Paessler, David L. Porter, Jenny L. Bush, Don L. Siegel, Megan M. Davis, Donglan Zhang, Carl H. June, Stephan A. Grupp, J. Joseph Melenhorst, Simon F. Lacey, Scott L. Weiss, David T. Teachey
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5174–5183.
https://doi.org/10.1182/bloodadvances.2020002592
Published: 2020
Includes: Supplemental data
Journal Articles

Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease

Hitomi Hosoya, Jeffrey Levine, Peter Abt, David Henry, David L. Porter, Saar Gill
Journal: Blood Advances
Blood Adv (2018) 2 (5): 575–585.
https://doi.org/10.1182/bloodadvances.2017012500
Published: 2018
Journal Articles

Somatic HLA mutations expose the role of class I–mediated autoimmunity in aplastic anemia and its clonal complications

Daria V. Babushok, Jamie L. Duke, Hongbo M. Xie, Natasha Stanley, Jamie Atienza, Nieves Perdigones, Peter Nicholas, Deborah Ferriola, Yimei Li, Hugh Huang, Wenda Ye, Jennifer J. D. Morrissette, Jane Kearns, David L. Porter, Gregory M. Podsakoff, Laurence C. Eisenlohr, Jaclyn A. Biegel, Stella T. Chou, Dimitrios S. Monos, Monica Bessler, Timothy S. Olson
Journal: Blood Advances
Blood Adv (2017) 1 (22): 1900–1910.
https://doi.org/10.1182/bloodadvances.2017010918
Published: 2017
Includes: Supplemental data